Earnings Ahead

OMI - Owens & Minor Inc

18.85 0.14 0.75

Owens & Minor Inc

Owens & Minor Inc

About

Profile

We provide sustainable supply chain, product, and patient solutions that lower total costs and improve quality of care across the continuum of care.


Headquarters

Virginia, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

OMI



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Nanobiotix, Owens & Minor top healthcare gainers; Soligenix, DermTech among losers
  • Owens & Minor beats Q1 top and bottom line estimates; revises FY23 outlook
  • Owens & Minor Q1 2023 Earnings Preview
  • Owens & Minor Non-GAAP EPS of $0.28 misses by $0.12, revenue of $2.55B beats by $90M, introduces FY23 outlook
  • Owens & Minor Q4 2022 Earnings Preview
  • Owens & Minor Non-GAAP EPS of $0.41 beats by $0.02, revenue of $2.5B beats by $100M
  • Owens & Minor Q3 2022 Earnings Preview
  • Owens & Minor cut at Citi on increased risk, lack of management clarity
  • Owens & minor slips pre market on lowering FY guidance, announces executive leadership team changes
  • Citi picks best Buy and Sell stocks in all sectors, leaning to quality and momentum
  • Owens & Minor reports Q2 earnings miss; narrows FY22 outlook
  • Owens & Minor Q2 2022 Earnings Preview
  • Owens & Minor awarded $1.125B Defense Department contract modification
  • Owens & Minor Non-GAAP EPS of $0.96 beats by $0.14, revenue of $2.41B beats by $100M
  • Owens & Minor Q1 2022 Earnings Preview
  • Owens & Minor resumed with a buy at Citi as Apria acquisition strengthens DME position
  • Owens & Minor prices upsized senior notes offering
  • Owens & Minor to raise $500M through debt offering
  • Apria GAAP EPS of $0.44 misses by $0.02, revenue of $296.5M beats by $3.48M
  • Owens & Minor projects lower than expected guidance despite Q4 earnings beat
Date Price Open High Low Vol Change ER
May 2 35.54 35.44
36.27
34.93
1.02M 0.14%
Apr 29 35.49 36.34
37.37
35.29
892.31K -3.45%
Apr 28 36.76 36.78
37.45
36.26
583.47K -0.05%
Apr 27 36.78 37.80
38.17
36.78
765.70K -2.88%
Apr 26 37.87 38.48
39.20
37.76
1.67M -1.51%
 
Apr 25 38.45 39.22
39.35
37.31
1.08M -3.08%
Apr 22 39.67 41.50
41.50
38.87
711.64K -4.89%
Apr 21 41.71 41.40
42.12
40.52
478.72K 0.85%
Apr 20 41.36 42.39
43.51
41.30
448.82K -2.06%
Apr 19 42.23 43.10
43.73
42.18
582.46K -2.11%
Apr 18 43.14 43.06
43.69
42.69
481.72K -1.17%
Apr 14 43.65 44.08
44.84
43.03
666.89K -0.25%
Apr 13 43.76 43.07
44.10
42.87
447.75K 1.77%
Apr 12 43.00 42.62
43.02
42.26
524.90K 1.34%
Apr 11 42.43 42.34
43.71
42.10
875.05K 0.09%
Apr 8 42.39 41.45
43.51
41.39
849.14K 2.39%
Apr 7 41.40 40.89
41.71
39.72
706.31K 0.73%
Apr 6 41.10 40.93
42.10
40.44
787.82K 0.02%
Apr 5 41.09 43.05
43.48
40.96
805.78K -4.17%
Apr 4 42.88 43.28
43.44
41.74
605.75K -1.38%